Close
Menu
The Society of Family Planning is relieved by the Supreme Court (SCOTUS) decision in United States Food and Drug Administration (FDA) v Alliance for Hippocratic Medicine (AHM). In a unanimous decision, the Court held that AHM, the plaintiffs, did not have standing. This means that the case will be sent back to the lower court to decide whether to dismiss the claims brought by AHM.
Research
In pursuit of our vision of just and equitable abortion informed by science, the Society supports and uplifts research regarding the safety and efficacy of medication abortion.
- Increasing access to medication abortion
- Innovations in medication abortion service delivery
- Capturing tradeoffs in abortion care
- Science Says: Telehealth medication abortion is safe and effective
- #WeCount quarterly reports on the changes in abortion volumes following the Dobbs ruling
Clinical guidance
To support clinicians who administer medication abortion, the Society provides evidence-informed and person-centered guidance.
- SFP clinical recommendation: Medication abortion between 14 0/7 and 27 6/7 weeks of gestation
- SFP interim clinical recommendation: Self-managed abortion
- Medication abortion up to 70 days of gestation
- Medication abortion with misoprostol-only: A sample protocol
Learning
The Society supports ongoing learning about medication abortion for clinicians, scholars, and advocates.